The Board of OncoSil Medical Ltd. advised that Dr. Martin Cross has resigned from the OncoSil board after 5 ½ years as a Non-Executive Director of the Company. The resignation will take effect immediately and furthers the renewal of the Board, over the past 15 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -44.44% |
05-23 | Oncosil Medical Enters Distribution Agreement with Abdulla Fouad Group for Saudi Arabia | MT |
05-02 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 11.1M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.32% | 238B | |
+7.05% | 204B | |
-6.05% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- OncoSil Medical Limited Announces Resignation of Martin Cross as Director